Depo-Provera: The Brain Tumor Risk Behind the Birth Control Shot

What Millions of Women Were Never Told

For more than thirty years, Depo-Provera has been one of the most widely used birth control methods in America. One injection every three months, no daily pill to remember, and millions of women trusted it. What those women were not told is that researchers have linked prolonged use of the drug to meningioma, a tumor that forms in the layers of tissue covering the brain. Regulators in Europe, the United Kingdom, and Canada added meningioma warnings to the drug's labeling back in 2024. American women did not get that warning until December 2025. At Jason Joy & Associates, we believe a company that knows about a risk has a duty to say so.


Depo-Provera Products Linked to Brain Tumors

These claims involve injectable medroxyprogesterone acetate, the active ingredient sold under the Depo-Provera name and by several authorized distributors. The shot is usually given at a clinic or a doctor's office roughly once every three months. If you received any of the following injections and were later diagnosed with a meningioma, you may have a claim:


  • Depo-Provera® CI (medroxyprogesterone acetate, 150 mg)
  • depo-subQ provera 104® (medroxyprogesterone acetate, 104 mg)
  • Medroxyprogesterone acetate injection by Greenstone
  • Medroxyprogesterone acetate injection by Prasco
  • Medroxyprogesterone acetate injection by Viatris
  • Generic medroxyprogesterone acetate injection


Warning Signs and Medical Symptoms

Meningiomas grow slowly, and many women live with one for years before anything feels wrong. Symptoms depend on where the tumor sits and what it presses against. Headaches that will not go away are common. So are blurred or double vision, hearing loss, ringing in the ears, and a fading sense of smell. Some women develop seizures, memory trouble, numbness or weakness in an arm or a leg, or changes in personality that family members tend to notice first. Any of these signs deserves a prompt evaluation by a physician.


We Fight for Compensation on Your Behalf

Our firm represents women who were injured by a product they were told was safe. We are pursuing claims that the manufacturers had information connecting long-term Depo-Provera use to meningioma and failed to put it in front of patients or the doctors treating them. If you have been diagnosed, we can help you build a claim for the surgery and radiation you already paid for, the care you still need, the income you lost, and what this has cost you personally. Pfizer has a legal department bigger than most law firms. You should not face it alone.


Do You Qualify? Criteria for Compensation

Claims involving Depo-Provera and meningioma generally require:


  • Documented Use: Proof that you received Depo-Provera, depo-subQ provera 104, or a generic medroxyprogesterone acetate injection.
  • Diagnosis: A meningioma confirmed by a physician, usually through an MRI, a CT scan, or surgical pathology.
  • Timeline: Your last injection came after 1992, the year the shot was approved for birth control in the United States.
  • Records: You can identify the clinic, the provider, or the pharmacy that gave you the shot or filled the prescription.
  • No Current Counsel: You are not already represented by another attorney on this claim.


If you only ever received a generic version, you may still qualify depending on which state you live in. Ask us. Meeting these criteria does not guarantee representation or compensation, and every case is reviewed on its own facts.


Contact Us Today to Protect Your Rights

Timing decides these cases as much as the medicine does. Each state sets its own filing deadline, and once yours passes, the courthouse door closes no matter how strong the claim was. The Depo-Provera litigation is also moving quickly right now. Contact Jason Joy & Associates today for a free, no obligation review of your case.

Depo-Provera Claims Quick Facts

A meningioma is a tumor that forms on the meninges, the protective layers wrapped around the brain and spinal cord. Roughly eighty percent are not cancerous. But location matters more than grade does. A benign tumor pressing against the optic nerve can still take your sight, and removing one means brain surgery.

A French national study published in The BMJ in March 2024 reported that women who used injectable medroxyprogesterone acetate for a year or longer had roughly five times the odds of developing a meningioma that required surgery. Researchers in Sweden and Denmark have since reported similar associations in their own national health data.

The federal cases are consolidated as MDL 3140 before Judge M. Casey Rodgers in the Northern District of Florida, where more than six thousand claims are pending. Pfizer and court-appointed plaintiffs' leadership signed a settlement agreement in July 2026. Its terms are confidential, and the litigation is continuing.

The most severe adverse effect linked to these drugs is NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy). This condition causes a lack of blood flow to the optic nerve, resulting in sudden, often permanent blindness or significant visual field defects. Unlike other side effects, vision loss from NAION is typically irreversible.

A pivotal study published in JAMA Ophthalmology (July 2024) by researchers at Harvard Medical School found a significant correlation between semaglutide and NAION. The data suggested that patients taking these drugs for weight loss were up to seven times more likely to be diagnosed with this blinding condition than those on other medications.

Pharmaceutical companies employ armies of defense attorneys to protect their profits and deny liability. Retaining professional legal counsel is essential to level the playing field. An experienced attorney navigates complex medical evidence, files in the appropriate courts (such as multidistrict litigation), and fights to maximize the compensation you are owed.

The most severe adverse effect linked to these drugs is NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy). This condition causes a lack of blood flow to the optic nerve, resulting in sudden, often permanent blindness or significant visual field defects. Unlike other side effects, vision loss from NAION is typically irreversible.

A pivotal study published in JAMA Ophthalmology (July 2024) by researchers at Harvard Medical School found a significant correlation between semaglutide and NAION. The data suggested that patients taking these drugs for weight loss were up to seven times more likely to be diagnosed with this blinding condition than those on other medications.

Pharmaceutical companies employ armies of defense attorneys to protect their profits and deny liability. Retaining professional legal counsel is essential to level the playing field. An experienced attorney navigates complex medical evidence, files in the appropriate courts (such as multidistrict litigation), and fights to maximize the compensation you are owed.

Trust A Firm With Over 10 Years Of Experience In Fighting For Others

Common

Questions


Common

Questions


Common

Questions


01

How much does it cost to hire you?

At Jason Joy & Associates, we work on a contingency fee basis. This means you pay nothing upfront to hire us. We front the cost of investigating your claim, ordering your medical and pharmacy records, and litigating the case from start to finish. A legal fee comes out only if we recover money for you through a settlement or a verdict. If there is no recovery, you owe us nothing.

02

What is Depo-Provera?

Depo-Provera is a prescription birth control shot containing medroxyprogesterone acetate, a synthetic form of the hormone progesterone. A nurse or a doctor injects it once every three months, which is part of why so many women chose it over a daily pill. The FDA approved it for contraception in 1992. It is also sold as depo-subQ provera 104, a lower dose given under the skin that also treats endometriosis pain.

03

Is there a legal solution for women affected by Depo-Provera?

Yes. Women diagnosed with meningioma after using the shot are filing product liability claims against Pfizer and related companies. These are individual lawsuits grouped for efficiency in an MDL, not a class action, so each woman's case is valued on her own injuries. A claim can seek compensation for surgery and radiation, ongoing treatment, permanent disability, lost earnings, and the physical and emotional toll of the diagnosis.

04

How do I know if I qualify?

Qualification comes down to three things: use, diagnosis, and timing. You need to have received Depo-Provera or a generic medroxyprogesterone acetate injection, with your last shot coming sometime after 1992. You need a meningioma diagnosis that a physician confirmed through imaging or pathology. And the diagnosis has to have followed your injections rather than preceded them. A short conversation with our office is the fastest way to find out where you stand.

Get Started With a Free Consultation

Contact Us

OR

Get Started With a Free Consultation

Contact Us

OR